BOXABL Inc.

2024 Q2 Form 10-Q Financial Statement

#000149315224033168 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q2

Balance Sheet

Concept 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $5.647M $11.77M
Short-Term Investments
Other Short-Term Assets $749.0K
YoY Change
Inventory $20.43M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $52.34M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $9.327M
YoY Change
Goodwill
YoY Change
Intangibles $349.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $26.99M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $52.34M
Total Long-Term Assets $26.99M
Total Assets $79.33M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.615M
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.92M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $13.92M
Total Long-Term Liabilities
Total Liabilities $22.87M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$701.4M
YoY Change
Common Stock $30.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $56.46M $91.00M
YoY Change
Total Liabilities & Shareholders Equity $79.33M
YoY Change

Cashflow Statement

Concept 2024 Q2 2023 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56579
dei Entity Registrant Name
EntityRegistrantName
BOXABL Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2511929
dei Entity Address Address Line1
EntityAddressAddressLine1
5345 E. N. Belt Road
dei Entity Address City Or Town
EntityAddressCityOrTown
North Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89115
dei City Area Code
CityAreaCode
(702)
dei Local Phone Number
LocalPhoneNumber
500-9000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5647000 usd
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
22888000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
22873000 usd
CY2024Q2 us-gaap Customer Deposits Current
CustomerDepositsCurrent
3750000 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2588000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3335000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2322000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13918000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8955000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
BOXABL Increase Decrease In Escrow Receivable
IncreaseDecreaseInEscrowReceivable
usd
BOXABL Payment For Security Deposits
PaymentForSecurityDeposits
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
BOXABL Acquisition Of Intellectual Property
AcquisitionOfIntellectualProperty
usd
BOXABL Acquisition Of Right Of Use Asset
AcquisitionOfRightOfUseAsset
usd
BOXABL Investments Held In Escrow
InvestmentsHeldInEscrow
usd
BOXABL Non Cash Deemed Dividends
NonCashDeemedDividends
usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
usd
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.00001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3000000000 shares
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
28535000 usd
CY2024Q2 BOXABL Escrow Receivable
EscrowReceivable
2633000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
20426000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
749000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
52343000 usd
CY2024Q2 us-gaap Long Term Investments
LongTermInvestments
234000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
3820000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9327000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
349000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11652000 usd
CY2024Q2 BOXABL Deposits On Equipment
DepositsOnEquipment
207000 usd
CY2024Q2 BOXABL Deposits Noncurrent
DepositsNoncurrent
1399000 usd
CY2024Q2 BOXABL Property Plant And Equipment Other Assets
PropertyPlantAndEquipmentOtherAssets
26988000 usd
CY2023Q4 BOXABL Property Plant And Equipment Other Assets
PropertyPlantAndEquipmentOtherAssets
41870000 usd
CY2024Q2 us-gaap Assets
Assets
79331000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1615000 usd
CY2024Q2 BOXABL Subscription Liability
SubscriptionLiability
308000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6600000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6600000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3000000000.00 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3000000000.00 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3000000000.00 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3000000000.00 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
30000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16999000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-701369000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
56458000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79331000 usd
us-gaap Revenues
Revenues
708000 usd
us-gaap Cost Of Revenue
CostOfRevenue
7332000 usd
us-gaap Gross Profit
GrossProfit
-6624000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7571000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5060000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3579000 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
12120000 usd
us-gaap Operating Expenses
OperatingExpenses
28330000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-34954000 usd
us-gaap Interest Income Other
InterestIncomeOther
869000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
108000 usd
us-gaap Other Income
OtherIncome
93000 usd
CY2023Q2 us-gaap Other Income
OtherIncome
12000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1070000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33884000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3000000 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3000000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3000000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
94680000 usd
CY2023Q2 BOXABL Stock Issued During Period Value New Issues Two
StockIssuedDuringPeriodValueNewIssuesTwo
3059000 usd
CY2023Q2 BOXABL Stock Issued During Period Value New Issues On Common Control Transacation
StockIssuedDuringPeriodValueNewIssuesOnCommonControlTransacation
30000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
29725000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-324000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2320000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-9273000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
73339000 usd
CY2024Q2 BOXABL Stock Issued During Period Value New Issues Three
StockIssuedDuringPeriodValueNewIssuesThree
3145000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-76000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1881000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-21831000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
56458000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
97564000 usd
BOXABL Stock Issued During Period Value New Issues Two
StockIssuedDuringPeriodValueNewIssuesTwo
6005000 usd
BOXABL Stock Issued During Period Value New Issues On Common Control Transacation
StockIssuedDuringPeriodValueNewIssuesOnCommonControlTransacation
30000000 usd
us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
29725000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-457000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2870000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15516000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
90741000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
82348000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
82348000 usd
BOXABL Stock Issued During Period Value New Issues Three
StockIssuedDuringPeriodValueNewIssuesThree
3145000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-76000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4925000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33884000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
56458000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
56458000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33884000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15516000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
953000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
812000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4925000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2870000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
108000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
951000 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
12120000 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
108000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-26000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
67000 usd
BOXABL Increase Decrease In Escrow Receivable
IncreaseDecreaseInEscrowReceivable
231000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1499000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6146000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
505000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-129000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1224000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
71000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-96000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-34000 usd
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-237000 usd
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-41000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
277000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-109000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
34000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-82000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18987000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18956000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1363000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4304000 usd
BOXABL Payment For Security Deposits
PaymentForSecurityDeposits
259000 usd
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
21001000 usd
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
45244000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
13553000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
25352000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5826000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15588000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
437000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
5550000 usd
BOXABL Proceeds From Accrual Of Subscription Liability
ProceedsFromAccrualOfSubscriptionLiability
-141000 usd
BOXABL Proceeds From Accrual Of Subscription Liability
ProceedsFromAccrualOfSubscriptionLiability
558000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
296000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6108000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12865000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2740000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22332000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9025000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9467000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11765000 usd
BOXABL Acquisition Of Intellectual Property
AcquisitionOfIntellectualProperty
272000 usd
BOXABL Acquisition Of Right Of Use Asset
AcquisitionOfRightOfUseAsset
12121000 usd
BOXABL Investments Held In Escrow
InvestmentsHeldInEscrow
2632000 usd
BOXABL Non Cash Deemed Dividends
NonCashDeemedDividends
-29725000 usd
BOXABL Purchase Of Asset From Deposits On Equipment
PurchaseOfAssetFromDepositsOnEquipment
-2134000 usd
BOXABL Purchase Of Asset From Deposits On Equipment
PurchaseOfAssetFromDepositsOnEquipment
-2575000 usd
BOXABL Purchase Of Assets In Acounts Payable
PurchaseOfAssetsInAcountsPayable
490000 usd
BOXABL Purchase Of Assets In Acounts Payable
PurchaseOfAssetsInAcountsPayable
447000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5647000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11765000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
3820000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9467000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11765000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zJBqbtBdUkm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zbT2dJGTOHH4">Prior Period Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified to conform to the current period presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zHkiThgqao7b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zgS7PBv0pq89">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures in the unaudited interim condensed consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates. These estimates form the basis for judgements the Company makes about the carrying value of its assets and liabilities, which are not readily apparent from other sources. These estimates are based on information available as of the date of the unaudited interim condensed consolidated financial statements, including historical information and various other assumptions that the Company believes are reasonable under the circumstances. Actual results could differ materially from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Security Deposit
SecurityDeposit
3714000 usd
CY2024Q1 BOXABL Additional Security Deposit
AdditionalSecurityDeposit
259000 usd
CY2024Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P14Y
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zy828fDFmIE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z0WxXNbrj8k4">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash and Cash Equivalents:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies all highly liquid instruments with an original maturity of three months or less as cash equivalents. Due to the maturity of cash equivalents, the carrying amounts of these instruments approximate their fair values. Financial instruments that potentially expose the Company to a concentration of credit risk consist primarily of cash and cash equivalents. Cash and cash equivalents are maintained at high quality financial institutions. As of June 30, 2024 and December 31, 2023, the Company’s deposits exceeded the Federal Deposit Insurance Corporation (FDIC) limit. The Company has not experienced any losses with respect to its cash balances. Based upon assessment of the financial condition of these institutions, management considers that the risk of loss of any uninsured balances does not have a significant impact on the Company’s operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Customers:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three and six months ended June 30, 2024, revenues from one customer were approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240401__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomersMember_zICmYARh2A1h" title="Concentration risk percentage"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomersMember_zO9VoWHR9Klk" title="Concentration risk percentage">73</span></span>% and revenues from four customers were <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240401__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_z8rO3o3XIF61" title="Concentration risk percentage"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240101__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zOLhPL9yRmzc" title="Concentration risk percentage">84</span></span>% of the Company’s revenues, respectively. As of June 30, 2024 the Company had no receivables from customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three and six months ended June 30, 2023, revenues from one customer were approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomersMember_zrVscBHb5Dm4" title="Concentration risk percentage"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomersMember_zgyrTV9jiW9f" title="Concentration risk percentage">99</span></span>% and revenues from two customers were <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zAJLZU5kgxQk" title="Concentration risk percentage"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zkiGS0X7MqR3" title="Concentration risk percentage">95</span></span>% of the Company’s revenues, respectively. As of December 31, 2023, receivables from two customers represented <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--AccountsReceivablesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zsPbejFU6pRk" title="Concentration risk percentage">92</span>% of the Company’s accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1356064000 shares
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1353522000 shares
BOXABL Product Warranty Term
ProductWarrantyTerm
P1Y
us-gaap Net Income Loss
NetIncomeLoss
-33884000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18987000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-701369000 usd
CY2024Q2 us-gaap Investments
Investments
23122000 usd
CY2023Q4 us-gaap Investments
Investments
30462000 usd
CY2024Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
3002000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
3346000 usd
CY2024Q2 us-gaap Other Inventory In Transit
OtherInventoryInTransit
295000 usd
CY2023Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
273000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
255000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17129000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
14820000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
20426000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
18694000 usd
CY2024Q2 us-gaap Inventory Write Down
InventoryWriteDown
198000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13266000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13840000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3939000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3074000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9327000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10766000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
467000 usd
CY2024Q2 BOXABL Deposits Written Off
DepositsWrittenOff
8164000 usd
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-12120000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-12120000 usd
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-108000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-108000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-12120000 usd
CY2023Q2 BOXABL Non Cash Deemed Dividends
NonCashDeemedDividends
29725000 usd
CY2020Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P65M
CY2020Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
173000 sqft
CY2020Q4 us-gaap Security Deposit
SecurityDeposit
525000 usd
CY2020Q4 us-gaap Payments For Rent
PaymentsForRent
87000 usd
CY2020Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
19000 usd
CY2023Q3 us-gaap Payments For Rent
PaymentsForRent
116 usd
CY2023Q3 BOXABL Rents Increase Percentage
RentsIncreasePercentage
0.04 pure
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P73M
CY2022Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
132960 sqft
CY2022Q2 us-gaap Payments For Rent
PaymentsForRent
104000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
19000 usd
CY2022Q2 BOXABL Rents Increase Percentage
RentsIncreasePercentage
0.04 pure
CY2023Q1 us-gaap Payments For Rent
PaymentsForRent
7409000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1946000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3997000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3839000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2102000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1509000 usd
CY2024Q2 BOXABL Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
257000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13650000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1360000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12290000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2024Q2 BOXABL Operating Lease Weighted Average Incremental Rate Percent
OperatingLeaseWeightedAverageIncrementalRatePercent
0.052 pure
CY2023Q4 BOXABL Operating Lease Weighted Average Incremental Rate Percent
OperatingLeaseWeightedAverageIncrementalRatePercent
0.052 pure
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04 pure
CY2024Q2 us-gaap Security Deposit Liability
SecurityDepositLiability
259000 usd
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4250000000 shares
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
750000000 shares
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
10-for-1 stock split
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6600000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1250000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
13400000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1232666 shares
CY2024Q2 BOXABL Preferred Stock Liquidation Preference Shares
PreferredStockLiquidationPreferenceShares
219487000 shares
CY2024Q2 us-gaap Escrow Deposit
EscrowDeposit
2633000 usd
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
232000 usd
CY2024Q2 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
76000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
76000 usd
CY2023Q2 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
324000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
457000 usd
CY2024Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
95000 usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0 usd
CY2024Q2 BOXABL Subscription Liability
SubscriptionLiability
308000 usd
CY2023Q4 BOXABL Subscription Liability
SubscriptionLiability
451000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.14
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
17900000 usd
CY2023 us-gaap Loss Contingency Damages Sought
LossContingencyDamagesSought
The Company anticipates that judgment will be entered in its favor for a sum less than $1,000,000, but the investigation and extent of damages is ongoing.
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
boxabl-20240630_cal.xml Edgar Link unprocessable
0001493152-24-033168-index-headers.html Edgar Link pending
0001493152-24-033168-index.html Edgar Link pending
0001493152-24-033168.txt Edgar Link pending
0001493152-24-033168-xbrl.zip Edgar Link pending
boxabl-20240630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex9-1.htm Edgar Link pending
ex9-1_001.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
boxabl-20240630_def.xml Edgar Link unprocessable
boxabl-20240630_lab.xml Edgar Link unprocessable
boxabl-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending